Effect of the P-selectin Inhibitor Crizanlizumab on Survival Free of Organ Support in Patients Hospitalized for COVID-19: A Randomized Controlled Trial
ISTH Academy. Lowenstein C. 06/25/23; 395390; LB 01.5
Topic: Other
CLICK HERE TO LOGIN
PREMIUM CONTENT
PREMIUM CONTENT
Access to Premium content is currently a membership benefit.
Click here to join ISTH or renew your membership.
Discussion Forum (0)
Rate & Comment (0)
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}